KoreaTimes - Bio

The Korea Times

The Korea Times

The Korea Times

Business

Bio

Mon, December 11, 2023 | 04:46

SK Bioscience recruits experts for global expansion

SK Bioscience recruits experts for global expansion

SK Bioscience, developer of SKYCovione, Korea's first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday. The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch,...

2023-01-20 14:40

Korea to invest $222.9 million in bio RD projects in 2023

Korea to invest $222.9 million in bio RD projects in 2023

Korea will extend 274.6 billion won ($222.9 million) for research and development in the bio industry this year, the industry ministry said Friday.

2023-01-20 10:35

S. Korea seeks to attract $500 mil. in investment from two European bio firms

S. Korea seeks to attract $500 mil. in investment from two European bio firms

South Korea's Industry Minister Lee Chang-yang met with top executives of Germany's Merck Life Science and Switzerland-based Novartis on Thursday in Davos, Switzerland, to discuss their potential investment in South Korea worth $500 million combined, his office said.

2023-01-19 20:22

SK Biopharmaceuticals to unveil wearable devices at CES 2023

SK Biopharmaceuticals to unveil wearable devices at CES 2023

SK Biopharmaceuticals will unveil its wearable healthcare devices at the upcoming Consumer Electronics Show (CES) next month as part of its plan to advance into the digital healthcare business, its head of R&D said Wednesday. “The bio industry is changing by converging with ICT. We believe there will be a patient-centric period in the bio industry and we will try to lead the ...

2022-12-14 16:35

CHA Vaccine Institute to develop mixed vaccine for COVID-19, influenza

CHA Vaccine Institute to develop mixed vaccine for COVID-19, influenza

CHA Vaccine Institute is developing a mixed vaccine that can offer protection against both COVID-19 and influenza as part of its efforts to prevent multiple diseases with a single dose, the biotech company said Tuesday. The company said it has been developing the mixed vaccine using its own immunity-enhancing platform, L-pampo, to increase immunity against both COVID-19 and i...

2022-12-13 17:08

Gov't seeks to accelerate innovation in bio industry with AI, big data

Gov't seeks to accelerate innovation in bio industry with AI, big data

The government has unveiled a plan to speed up innovation in the biopharmaceutical industry by introducing advanced digital technologies such as artificial intelligence and big data, according to the Ministry of Science and ICT, Wednesday.

2022-12-07 16:25

Seegene struggles to stay afloat as pandemic ebbs

Seegene struggles to stay afloat as pandemic ebbs

Seegene, which had enjoyed the soaring popularity of its COVID-19 PCR test kits, has been struggling to stay afloat as the pandemic has been ebbing, according to industry analysts, Monday. They said the time has passed for Seegene to enjoy high growth as the number of COVID-19 infections has gradually declined globally and much of the world is shifting to endemic mode.

2022-11-14 16:51

'Agility, digitalization are key edges of Samsung Biologics'

'Agility, digitalization are key edges of Samsung Biologics'

FRANKFURT - Samsung Biologics has been increasing its presence in the global contract development and manufacturing organization (CDMO) business, generating larger revenues than market expectations this year. Such growth was possible thanks to its agile response to improve production capacity and achieving a digital transformation, according to its executives, Tuesday.

2022-11-07 14:11

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

FRANKFURT - Robert Yu, president and CEO of Yuyu Pharma, said Wednesday that his mission is to make the company comparable to prominent biopharmaceutical companies in the world. To that end, he said the Korean company is actively diversifying its portfolio by developing new drugs such as a dry eye treatment as well as hair loss medication.

2022-11-06 11:51

Contract manufacturing emerges as new opportunity for Korean bio firms

Contract manufacturing emerges as new opportunity for Korean bio firms

FRANKFURT - The CPHI exhibition has become a place for finding new growth engines for Yungjin Pharm, Daewon Pharmaceutical, Kyongbo Pharm and other small Korean bio companies as they actively try to attract new clients for their contract manufacturing organization (CMO) business, according to the companies, Wednesday.

2022-11-03 16:09

1 2 3 4 5 6 7 8 9 10

Top 10 Stories

1	Methods to avoid YouTube, Netflix restrictions go viral

2	Anti-dog meat legislation looks doomed as Assembly session ends in vain

3	N. Korea's fear of external info grows after Seoul allows sending propaganda leaflets

4	Hunting 'crow thief' on Korea's east coast in 1930s

5	Leaders of Samsung, SK to visit Netherlands for chip alliance

6	Skepticism mounts over shareholder activism at Samsung C&T

7	Calls grow for shift from two-party political system

8	Eximbank teams up with US counterpart on decarbonization

9	'New initiative on NK' lacks balanced strategy: experts

10	Gov't boosts reserves to appease public jitters over urea shortage

DARKROOM